Trademark: 88727180
Status Date
Monday, May 23, 2022
Filing Date
Friday, December 13, 2019
Published for Opposition
Tuesday, August 25, 2020
Abandoned Date
Monday, May 23, 2022
5 Implant delivery agent in the form of a bioerodible drug delivery implant for subdermal implantation which facilitates controlled release delivery of pharmaceutical preparations, veterinary preparations and nutrient compounds for use in treating diseases and disorders associated with inflammation; Implantable pharmaceutical preparations for the treatment of diseases and disorders associated with inflammation; Implantable veterinary preparations for the treatment of diseases and disorders associated with inflammation; Implantable nutrient compounds for use as a nutritional supplement
The wording GESEA has no meaning in a foreign language.
"BIOSCIENCES"
May 23, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
May 23, 2022
Abandonment - No Use Statement Filed
Sep 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 30, 2021
Sou Extension 2 Granted
Aug 30, 2021
Sou Extension 2 Filed
Aug 30, 2021
Teas Extension Received
Mar 20, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 18, 2021
Sou Extension 1 Granted
Mar 18, 2021
Sou Extension 1 Filed
Mar 18, 2021
Teas Extension Received
Oct 20, 2020
Noa E-Mailed - Sou Required From Applicant
Aug 25, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 25, 2020
Published For Opposition
Aug 5, 2020
Notification Of Notice Of Publication E-Mailed
Jul 20, 2020
Approved For Pub - Principal Register
Jul 10, 2020
Teas/Email Correspondence Entered
Jul 9, 2020
Correspondence Received In Law Office
Jul 9, 2020
Teas Response To Office Action Received
Mar 16, 2020
Notification Of Non-Final Action E-Mailed
Mar 16, 2020
Non-Final Action E-Mailed
Mar 16, 2020
Non-Final Action Written
Mar 13, 2020
Assigned To Examiner
Dec 17, 2019
New Application Office Supplied Data Entered
Dec 17, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
